| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/07/2003 | US20030148331 Novel human hepatoma associated protein and the polynucleotide encoding said polypeptide |
| 08/07/2003 | US20030148330 Enhancing domains; polymerases; thermal stability |
| 08/07/2003 | US20030148327 Nucleic acid of given sequence; oligonucleotides and oligomers for detecting the cytosine methylation of genes; tumors and cancer |
| 08/07/2003 | US20030148326 Diagnosis of diseases associated with dna transcription |
| 08/07/2003 | US20030148325 Infectious clones |
| 08/07/2003 | US20030148323 Analyzing nucleic acid and determining presence of mutant alleles encoding a protein with reduced activity/thermal stability; useful in diagnosing schizophrenia |
| 08/07/2003 | US20030148320 Of given sequence; has promoter activity thus enabling genetic manipulation |
| 08/07/2003 | US20030148319 Isolated nucleic acid; geranylgeranyl pyrophosphate synthase, zeaxanthin glucosyl transferase, lycopene cyclase and phytoene synthase; use in conversion of phytoene |
| 08/07/2003 | US20030148318 Glycosyltransferase activity; gene expressin; colorectal |
| 08/07/2003 | US20030148315 Increases complementarity in a heteroduplex polynucleotide sequence |
| 08/07/2003 | US20030148311 Aspartate carbamyltransferase as herbicidal target |
| 08/07/2003 | US20030148309 For enhanced recombinogenicity, genome copy number, and capacity for expression and/or secretion of proteins and secondary metabolites |
| 08/07/2003 | US20030148308 Target molecule attachment to surfaces |
| 08/07/2003 | US20030148306 Aggrecanase molecules |
| 08/07/2003 | US20030148302 Polymerase chain reaction (PCR); quantitating the presence of nucleic acid sequences by evaluation of amplification data; identifying threshold based upon exponential and baseline regions |
| 08/07/2003 | US20030148300 Encoded by nucleic acid molecule of given sequence; use in producing transgenic plants with increased levels of tocopherol |
| 08/07/2003 | US20030148299 Linearizing with restriction enzymes; ligating nucleotide sequence; transforming bacterial cells and selecting for colonies based on expression of the reporter molecule |
| 08/07/2003 | US20030148295 Endothelial cells; nucleotide sequences; microarrays; algorithms |
| 08/07/2003 | US20030148294 DNA encoding novel chemokine receptors |
| 08/07/2003 | US20030148290 By providing a means of detecting nucleotides, that are characteristic for methylated sites after bisulfite treatment of the genomic DNA; uses labels and detection of fluorescence resonance energy transfer (FRET) of amplified sample DNA |
| 08/07/2003 | US20030148287 Libraries and kits for detecting transcription factor activity |
| 08/07/2003 | US20030148285 Source of Immunodominant MHC-associated Peptides (SIMP); antibodies, probes, and cells, to characterize SIMP, modulate its cellular levels, diagnose and treat cancers and modulate immune response |
| 08/07/2003 | US20030148283 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 08/07/2003 | US20030148281 Nucleic acids encoding novel G-protein coupled receptors; use diagnosing or treating cancer, bone disorders, leukemia, cardiovascular disorders, brain disorders and hormonal disorders |
| 08/07/2003 | US20030148280 Oligonucleotide primer sets, probes; kits; detecting in test sample Human Immunodeficiency Virus Type 1 (HIV-1) |
| 08/07/2003 | US20030148278 Test kit and method for quantitatively detecting genetically modified DNA in foodstuff by means of fluorescence-coupled PCR |
| 08/07/2003 | US20030148277 Contacting a double-stranded target nucleic acid with a single-stranded competitor oligonucleotide (such as peptide nucleic acid) that is capable of hybridizing to one strand of the target; competitor has a net neutral or positive charge |
| 08/07/2003 | US20030148275 Nuclease |
| 08/07/2003 | US20030148274 Identification of neural defects associated with the nucleosomal assembly protein 112 gene |
| 08/07/2003 | US20030148273 Target enrichment and amplification |
| 08/07/2003 | US20030148271 Given amino acid sequence; expression vectors, host cells; diagnosis, prevention and treatment of diseases associated with expression of the kallikrein |
| 08/07/2003 | US20030148265 The factor allowing translocation is the homeodomain of antennapedia, and the viral protein can be from Flavivirus; fusion proteins as therapeutic agents |
| 08/07/2003 | US20030148264 PDZ (PSD-95/Discs large/ZO-I) domains, (PSD-95 = post-synaptic density protein-95); PDZ proteins involved in assembling ion channels and other transmembrane receptors, at specialized subcellular sites such as tight junctions |
| 08/07/2003 | US20030148263 Phage display; selection of ligands that bind to a cell surface receptor/moeity and internalize useful in delivery of molecules to the nucleus of a target cell; rolling circle amplification |
| 08/07/2003 | US20030148262 Chimeric alphavirus replicon particles |
| 08/07/2003 | US20030148261 Compositions and methods comprising West Nile virus polypeptides |
| 08/07/2003 | US20030148101 Porous ferro-or ferrimagnetic glass particles for isolating molecules |
| 08/07/2003 | US20030147966 Nanoparticle delivery vehicle |
| 08/07/2003 | US20030147958 Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents |
| 08/07/2003 | US20030147924 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/07/2003 | US20030147922 Vaccine against streptococcus pneumoniae capsular polysaccharides |
| 08/07/2003 | US20030147919 Producing empty, and thus non-infectious, parvovirus capsids, and to diagnostic assays and vaccines utilizing same; packaging and transferring nucleic acids |
| 08/07/2003 | US20030147916 Recombinant influenza a viruses |
| 08/07/2003 | US20030147915 Antibodies specific for seroreactive regions on HPV 16 proteins E1 and E2 |
| 08/07/2003 | US20030147912 Use generating immunity to human immunodeficiency virus-1 (HIV); also gene therapy for neurodegenerative disorders; AAV inverted terminal repeats flanking DNA sequences encoding an immunodeficiency virus protein and regulatory sequences |
| 08/07/2003 | US20030147909 Protein naturally obtained through the activation of the immune system of fish inoculated with the pathogen; for aquaculture |
| 08/07/2003 | US20030147907 Retroviral vectors |
| 08/07/2003 | US20030147905 Administering an oligopeptide for immunotherapy |
| 08/07/2003 | US20030147903 ABC transport polynucleotides, polypeptides and antibodies |
| 08/07/2003 | US20030147902 Method of stimulating and immune response by administration of host organisms that express intimin alone of as a fusion protein with one of more other antigens |
| 08/07/2003 | US20030147895 Constructs for delivery of threrapeutic agents to neuronal cells |
| 08/07/2003 | US20030147894 Useful in the field of remedies for myelocytic leukemia; binds to the myeloid cells |
| 08/07/2003 | US20030147893 Novel human transmembrane 4 superfamily protein |
| 08/07/2003 | US20030147887 B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 08/07/2003 | US20030147884 Administering a breast cancer patient (caused by human ErbB2 oncogene which codes a transmebrane glycoprotein receptor related to epidermal growth factor receptor, is overexpressed) an anti ErbB2 antibody and a drug |
| 08/07/2003 | US20030147880 Genetic engineered nucleotide sequences codes a recombinant protein for treating allergy |
| 08/07/2003 | US20030147873 Cell culture prodcut for treating a behavioral or psychological disorders and brian disorders, brain transplant; stem cells |
| 08/07/2003 | US20030147868 A gene therapy, transfecting cells with exogenous genetic DNA for coding a desired therapeutic proteins, culturing the cells, for large-scale protein production |
| 08/07/2003 | US20030147866 Novel BGP compounds for therapy and diagnosis and methods for using same |
| 08/07/2003 | US20030147864 Antisense modulation of CD36L1 expression |
| 08/07/2003 | US20030147863 Antisense modulation of TFAP2C expression |
| 08/07/2003 | US20030147862 Administering a colony stimulating factor and/or a nucleic acids encoding the factor; treating a vascular tumor |
| 08/07/2003 | US20030147856 Proteins |
| 08/07/2003 | US20030147855 Using a recombinant adeno-associated virus (rAAV) vector; useful for treating obesity and diabetes |
| 08/07/2003 | US20030147854 Adenovirus vectors for gene therapy |
| 08/07/2003 | US20030147853 Recombinant adeno-associated virus-mediated gene transfer via retroductal infusion of virions |
| 08/07/2003 | US20030147852 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/07/2003 | US20030147847 Isolated nucleic acid encoding a protein comprising a glycosylphosphatidyl inositol-1 polypeptide can enhance the cytolytic activity of peripheral blood mononuclear cells |
| 08/07/2003 | US20030147810 Compositions and methods for reporting of protease activity within the secretory pathway |
| 08/07/2003 | US20030147808 Single Chain Fv constructs of anti-ganglioside GD2 antibodies |
| 08/07/2003 | US20030146097 Buffers for electrophoresis and use thereof |
| 08/07/2003 | US20030146095 Methods for the electronic, Homogeneous assembly and fabrication of devices |
| 08/07/2003 | CA2849427A1 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 08/07/2003 | CA2714295A1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 08/07/2003 | CA2480012A1 Chimeric bird from embryonic stem cells |
| 08/07/2003 | CA2475003A1 Double-stranded oligonucleotides |
| 08/07/2003 | CA2474982A1 Computer systems and methods for identifying genes and determining pathways associated with traits |
| 08/07/2003 | CA2474910A1 Oligonucleotide compositions with enhanced efficiency |
| 08/07/2003 | CA2474908A1 Aggrecanase molecules |
| 08/07/2003 | CA2474898A1 Methods for creating recombination products between nucleotide sequences |
| 08/07/2003 | CA2474864A1 Methods and means for amplifying nucleic acid |
| 08/07/2003 | CA2474860A1 Methods for identifying polyadenylation sites and genes thereof |
| 08/07/2003 | CA2474855A1 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof |
| 08/07/2003 | CA2474810A1 Methods for retrotransposing long interspersed elements (lines) |
| 08/07/2003 | CA2474777A1 Adenoviral vectors for modulating the cellular activities associated with pods |
| 08/07/2003 | CA2474759A1 Gene for peripheral arterial occlusive disease |
| 08/07/2003 | CA2474724A1 Process for detecting predisposition to a cardiovascular disease |
| 08/07/2003 | CA2474659A1 Nucleic acid fragments for the identification of dechlorinating bacteria |
| 08/07/2003 | CA2474649A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 08/07/2003 | CA2474616A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/07/2003 | CA2474567A1 Amidases, nucleic acids encoding them and methods for making and using them |
| 08/07/2003 | CA2474497A1 Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 08/07/2003 | CA2474485A1 Light activated gene transduction using ultraviolet light for cell targeted gene delivery |
| 08/07/2003 | CA2474482A1 Methods for placing, accepting, and filling orders for products and services |
| 08/07/2003 | CA2474481A1 Method for operating a computer and/or computer network to distribute biotechnology products |
| 08/07/2003 | CA2474468A1 Amplifying repetitive nucleic acid sequences |
| 08/07/2003 | CA2474457A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 08/07/2003 | CA2474414A1 Oligonucleotides comprising alternating segments and uses thereof |
| 08/07/2003 | CA2474339A1 Multiple virus replicon culture systems |
| 08/07/2003 | CA2474091A1 Method of fixing biomolecule to carrier |